您的位置:
(4R,12aS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-b)(1,3)恶嗪-9-甲酰胺
(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
97% ( Chemicell/科米赛尔)
CAS号 | 1335210-35-9 | 试剂别名 | (4R,12aS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-b)(1,3)恶嗪-9-甲酰胺;DOLUTEGRAVIR 中间体;壬酸香草酯;(4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-甲酰胺;(4R,12aS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺;{ "\"0\"": "(4R,12aS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺" } |
分子式 | C21H21F2N3O5 | ||
分子量 | 433.41 | ||
英文名称: | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide |
英文别名: | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide;(4R,12AS)-N-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide |
中文别名: | (4R,12aS)-N-((2,4-二氟苯基)甲基)-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并(1',2':4,5)吡嗪并(2,1-b)(1,3)恶嗪-9-甲酰胺;DOLUTEGRAVIR 中间体;壬酸香草酯;(4R,12AS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12A-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-B][1,3]恶嗪-9-甲酰胺;(4R,12aS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺;{ "\"0\"": "(4R,12aS)-N-[(2,4-二氟苯基)甲基]-3,4,6,8,12,12a-六氢-7-甲氧基-4-甲基-6,8-二氧代-2H-吡啶并[1',2':4,5]吡嗪并[2,1-b][1,3]恶嗪-9-甲酰胺" } |
CAS No.: | 1335210-35-9 |
分子式: | C21H21F2N3O5 |
分子量: | 433.41 |
纯度: | 97% |